dr anna chacon semaglutide Top 5 Common Side Effects and How to Minimize Them Exploring beyond numeric weight loss:

What sets our practice apart includes: Board-certified providers who design and oversee each program with a strong understanding of weight management science Personalized plans shaped around medical history, lab results, lifestyle, and individual goals rather than a generic diet model Safe, monitored progress through regular check-ins and clinical oversight Evidence-based options that may include nutrition coaching and prescription therapies such as semaglutide or tirzepatide when appropriate Schedule your consultation for GLP-1 weight loss injections in Allen, TX

[DOI] [PubMed] [Google Scholar] 19.Larcombe S., Hutton M.L., Lyras D

12, 2026 /CNW/ - Novo Nordisk announced today that Health Canada has approved RYBELSUS (semaglutide tablets) to reduce the risk of major adverse cardiovascular (CV) events (CV death, non-fatal myocardial infarction or non-fatal stroke) in adults with type 2 diabetes mellitus who have established cardiovascular disease or are at high risk for these events.1,2 In Canada, cardiovascular disease remains a public health challenge, with heart disease as the second leading cause of death and a leading cause of hospitalization.4 It's estimated that 9 in 10 Canadians have at least one risk factor for stroke, heart disease, or vascular cognitive impairment including: sex, age, diabetes, family history and Indigenous, South Asian and African family heritage.5 Health Canada's approval of this indication is based on the results of the SOUL trial.2 Trial results confirmed that the risk of a major adverse cardiovascular event (MACE) decreased with the use of RYBELSUS as compared to a placebo, when used concomitantly with standard of care treatments for diabetes and cardiovascular disease.1 "This approval marks an important milestone for type 2 diabetes patients in Canada, who are at higher risk of cardiovascular events due to the chronic disease," says Vince Lamanna, President, Novo Nordisk Canada Inc

Compounded semaglutide carries a side-effect profile that largely mirrors what patients experience with brand-name products like Ozempic and Wegovy, experts say